Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
This study is currently recruiting participants.
Verified January 2013 by Case Comprehensive Cancer Center
Sponsor:
Brian Hill, MD, PhD
Collaborators:
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):
Brian Hill, MD, PhD, Case Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00671112
First received: May 2, 2008
Last updated: January 4, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |